New COVID-19 Cases Stay in 400s for 6 Consecutive Days... 17 More Vaccine Adverse Reactions Reported (Update)

396 Local Cases, 19 Imported Cases
Total 676,607 First Doses Administered...Vaccination Rate 84.6%

On the 22nd, citizens are waiting to get tested at the temporary COVID-19 screening site set up at Seoul Station Plaza. Photo by Moon Honam munonam@

[Asia Economy Reporter Kim Ji-hee] On the 22nd, the number of new domestic COVID-19 cases recorded 415, continuing the 400-range for the sixth consecutive day.

The Central Disease Control Headquarters (CDCH) announced that as of midnight, 415 new domestic COVID-19 cases were confirmed, bringing the total to 99,075. Regarding infection routes, 396 cases were locally transmitted, and 19 were imported cases.

By region, a majority of cases still emerged in the Seoul metropolitan area including Seoul and Gyeonggi, while Busan, Gyeongnam, and Gangwon also reported more than 20 cases. Seoul confirmed 108 cases, Gyeonggi 143 cases, and Incheon 10 cases. Among non-metropolitan areas, Gyeongnam reported 37 positive cases, followed by Busan with 24, Gangwon 21, Daegu 14, Chungnam 11, Gyeongbuk 10, Jeonbuk 7, Chungbuk 5, Gwangju and Jeonnam 2 each, and Jeju and Ulsan 1 each. No additional cases were reported in Daejeon and Sejong.

The cumulative number of COVID-19 deaths increased by one from the previous day to 1,697. The number of critically ill patients decreased by one to 103. The number of patients who were declared recovered and released from isolation increased by 283 to 90,611.

The total number of tests conducted on this day was 40,962. The number of diagnostic tests from suspected reports was 23,250. At temporary screening clinics set up in the metropolitan area, 17,712 tests were conducted, confirming 50 positive cases.

Meanwhile, the COVID-19 Vaccination Response Promotion Team reported that as of midnight, there were no new first-dose vaccinations, and a total of 676,607 people have completed the first dose. The vaccination rate stands at 84.6%.

The number of suspected adverse reactions reported after COVID-19 vaccination increased by 17 from the previous day, totaling 9,703 cases. All newly reported adverse reaction cases were mild.

This content was produced with the assistance of AI translation services.